P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM

Bibliographic Details
Main Authors: I. Aurer, S. Basic-Kinda, A. Grubesic, O. Jaksic, S. Mrdenovic, S. Novakovic-Coha, D. Lozic, M. Mikulic-Pisk, R. Serventi-Seiwerth, D. Dujmovic, A. Ostojic, B. Dreta, G. Pavlisa, M. Narancic, I. Hude-Dragicevic, T. Valkovic
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000849128.90079.53
_version_ 1797281244284715008
author I. Aurer
S. Basic-Kinda
A. Grubesic
O. Jaksic
S. Mrdenovic
S. Novakovic-Coha
D. Lozic
M. Mikulic-Pisk
R. Serventi-Seiwerth
D. Dujmovic
A. Ostojic
B. Dreta
G. Pavlisa
M. Narancic
I. Hude-Dragicevic
T. Valkovic
author_facet I. Aurer
S. Basic-Kinda
A. Grubesic
O. Jaksic
S. Mrdenovic
S. Novakovic-Coha
D. Lozic
M. Mikulic-Pisk
R. Serventi-Seiwerth
D. Dujmovic
A. Ostojic
B. Dreta
G. Pavlisa
M. Narancic
I. Hude-Dragicevic
T. Valkovic
author_sort I. Aurer
collection DOAJ
first_indexed 2024-03-07T16:54:46Z
format Article
id doaj.art-2de84b7767564b33a634a0ff665f31fe
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:54:46Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-2de84b7767564b33a634a0ff665f31fe2024-03-03T04:28:42ZengWileyHemaSphere2572-92412022-06-0161449145010.1097/01.HS9.0000849128.90079.53202206003-01449P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEMI. Aurer0S. Basic-Kinda1A. Grubesic2O. Jaksic3S. Mrdenovic4S. Novakovic-Coha5D. Lozic6M. Mikulic-Pisk7R. Serventi-Seiwerth8D. Dujmovic9A. Ostojic10B. Dreta11G. Pavlisa12M. Narancic13I. Hude-Dragicevic14T. Valkovic151 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb3 Division of Hematology, Department of Internal Medicine, University Hospital Centre Rijeka, Rijeka2 Medical School, University of Zagreb, Zagreb5 Division of Hematology, Department of Internal Medicine, University Hospital Centre Osijek, Osijek6 Division of Hematology, Department of Internal Medicine, University Hospital Centre Sisters of Mercy, Zagreb7 Division of Hematology, Department of Internal Medicine, University Hospital Centre Split, Split1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb2 Medical School, University of Zagreb, Zagreb9 Division of Hematology, Department of Internal Medicine, General Hospital Zadar, Zadar1 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb3 Division of Hematology, Department of Internal Medicine, University Hospital Centre Rijeka, Rijekahttp://journals.lww.com/10.1097/01.HS9.0000849128.90079.53
spellingShingle I. Aurer
S. Basic-Kinda
A. Grubesic
O. Jaksic
S. Mrdenovic
S. Novakovic-Coha
D. Lozic
M. Mikulic-Pisk
R. Serventi-Seiwerth
D. Dujmovic
A. Ostojic
B. Dreta
G. Pavlisa
M. Narancic
I. Hude-Dragicevic
T. Valkovic
P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
HemaSphere
title P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
title_full P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
title_fullStr P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
title_full_unstemmed P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
title_short P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
title_sort p1568 early but not late use of remdesvir and convalescent plasma reduces mortality of covid 19 in patients with hematologic malignancies a study of krohem
url http://journals.lww.com/10.1097/01.HS9.0000849128.90079.53
work_keys_str_mv AT iaurer p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT sbasickinda p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT agrubesic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT ojaksic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT smrdenovic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT snovakoviccoha p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT dlozic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT mmikulicpisk p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT rserventiseiwerth p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT ddujmovic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT aostojic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT bdreta p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT gpavlisa p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT mnarancic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT ihudedragicevic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem
AT tvalkovic p1568earlybutnotlateuseofremdesvirandconvalescentplasmareducesmortalityofcovid19inpatientswithhematologicmalignanciesastudyofkrohem